1. Indications and Usage
Chronic Constipation: Treatment of chronic constipation in adult women who have not been sufficiently relieved by laxatives.
2. Dosage and Administration
Recommended Dose: 2 mg once daily for adults.
Special Populations: 1 mg once daily for elderly patients (>65 years), and patients with severe renal impairment (GFR <30 mL/min/1.73m²) or severe hepatic impairment (Child-Pugh C class).
Administration: Oral administration, irrespective of meals.
Duration: If ineffective after 4 weeks, the patient should be re-evaluated.
3. Mechanism of Action
Target: High-affinity, selective agonist of serotonin 5-HT4 receptors.
Action: Enhances gastrointestinal motility by increasing peristaltic reflexes and propulsive motor patterns in the gut.
4. Safety and Warnings
Contraindications: Intestinal perforation, obstruction, or ileus; severe inflammatory bowel disease; or recent bowel surgery.
Gastrointestinal Events: Severe diarrhea may occur; treatment should be stopped immediately if it develops.
Cardiac Risks: Use with caution in patients with a history of cardiac arrhythmias or ischemic cardiovascular disease.
5. Adverse Reactions and Clinical Research
Adverse Reactions: The most common adverse reactions are headache and gastrointestinal symptoms (diarrhea, abdominal pain, or nausea), each occurring in approximately 20% of patients.
Clinical Research: Clinical trials have demonstrated good efficacy and safety in patients with chronic constipation.
6. Drug Interactions
CYP3A4 Inhibitors: Concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, clarithromycin) may increase exposure to prucalopride.
Oral Contraceptives: Severe diarrhea may reduce efficacy; alternative contraceptive methods are recommended during episodes of severe diarrhea.
Digoxin: Prucalopride may increase the plasma concentration of digoxin; close monitoring is advised.
7. Pharmaceutical Information
Composition: The active ingredient is prucalopride succinate.
Excipients: Includes lactose monohydrate.
Appearance: White or off-white film-coated tablets.
Storage: Store in a sealed container, protected from moisture.

Ruisheng Prucalopride Succinate Tablets
Brand Name: 瑞宜生®(Ruisheng®)
Generic Name: Prucalopride Succinate
Strength: Each tablet contains 2 mg prucalopride (calculated by C18H26ClN3O3), 7 tablets per box
Manufacturer: Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Marketing Authorization Holder: Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Approval Date in China: July 11, 2018
Registration Number: 国药准字H20183482
Storage: Seal tightly, store at room temperature protected from light and humidity. Keep out of the reach of children. Refer to the package insert for detailed storage requirements.
Price&Cost:Contact Us now for the best price of Prucalopride Succinate(Ruisheng)
Only logged in customers who have purchased this product may leave a review.





Reviews
There are no reviews yet.